Highlights
Clinical efficacy of alpha1-Adrenargic Receptor Antagonist in BPH patients
Wednesday, 28 July 2010- K. Kadekawa and colleagues assessed the clinical efficacy and safety of 75 mg/day of naftopidil, an alpha1-adrenargic receptor antagonist in patients with benign prostatic hyperplasia (BPH). They...
Edited by: JV
Clinical drawings for your patients: Prostate diseases and their treatments
Thursday, 10 June2010 - Men consulting a physician for prostate disease are increasingly wanting to be more informed about their disease. Although at present the Internet provides ample information which are easily available,...
By: Prof.Dr. Paul Meria
Fast Facts: Benign Prostatic Hyperplasia
Thursday, 10 June2010 - Benign prostatic hyperplasia (BPH) is the commonest disease in men over 50 years old and increases with age. Urologists are involved in BPH management which represents up to 80% of their clinical activity....
By: Prof.Dr. Paul Meria
FDA gives OK to first generic tamsulosin to treat BPH
Thursday, 4 March 2010- The US Food and Drug Administration has approved the first generic version of Flomax capsules 0.4 mg (tamsulosin hydrochloride) to treat benign prostatic hyperplasia (BPH), a condition in which an enlarged...
Edited by: JV
Combination therapy more effective for enlarged prostate
Thursday, 4 March 2010- Like any successful team effort, the best qualities of two drugs commonly prescribed for enlarged prostate yielded better results than either of the medicines alone, according to a new study from UT...
Edited by: ES
CombAT study shows superiority of combined treatment over monotherapy
Tuesday, 29 September 2009- Combination therapy with dutasteride and tamsulosin provides significantly greater benefit than either monotherapy for various patient-reported outcomes in men with moderate-to-severe lower urinary...
Edited by: ES
Incidence of PCa diagnosed incidentally in specimens taken during BPH surgery
Wednesday, 23 September 2009- In 2.8–9.8% of patients (pts) undergoing TURP or prostatectomy (PR) due to benign prostate hyperplasia (BPH), final pathological evaluation (PE) reveals coexistence of prostate cancer (PCa)....
Edited by: JV
Asymptomatic inflammatory prostatitis in ageing male with LUTS
Friday, 18 September 2009- Asymptomatic inflammation as new category of prostatitis is often found during evaluation of other reproductive and prostate disorders. Kristo Ausmees, et al. (Estonia) conducted a study to determine...
Edited by: JV
Combined dutasteride, tamsulosin treatment more efficient than monotherapy
Tuesday, 8 September 2009- The much-awaited results of the Combination of Avodart and Tamsulosin (CombAT) study that have been published recently online in the journal of Prostate Cancer and Prostatic Diseases, revealed that...
Edited by: ES
